IRF8 regulates myeloid and B lymphoid lineage diversification
about
Transcription factor IRF8 directs a silencing programme for TH17 cell differentiationPredominant Role of Plasmacytoid Dendritic Cells in Stimulating Systemic AutoimmunityInterferon-regulatory factors determine macrophage phenotype polarizationInterferon regulatory factor 8-deficiency determines massive neutrophil recruitment but T cell defect in fast growing granulomas during tuberculosisInterferon regulatory factor 8 (IRF8) interacts with the B cell lymphoma 6 (BCL6) corepressor BCORZFP36L1 negatively regulates erythroid differentiation of CD34+ hematopoietic stem cells by interfering with the Stat5b pathwayZbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineagesHematopoiesis in the equine fetal liver suggests immune preparedness.Innate defects of the IL-12/IFN-γ axis in susceptibility to infections by mycobacteria and salmonellaPolymorphisms in microRNA target sites modulate risk of lymphoblastic and myeloid leukemias and affect microRNA binding.Interferon regulatory factor 8 regulates pathways for antigen presentation in myeloid cells and during tuberculosisAssociation of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosusIFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in miceThe prolyl isomerase Pin1 modulates development of CD8+ cDC in mice.Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus.The transcription factors IRF8 and PU.1 negatively regulate plasma cell differentiation.Interleukin 27 induces the expression of complement factor H (CFH) in the retina.Enhancer sequence variants and transcription-factor deregulation synergize to construct pathogenic regulatory circuits in B-cell lymphoma.IFN regulatory factor 8 is a key constitutive determinant of the morphological and molecular properties of microglia in the CNS.Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer's disease.A capture-sequencing strategy identifies IRF8, EBF1, and APRIL as novel IGH fusion partners in B-cell lymphoma.Irf8-regulated genomic responses drive pathological inflammation during cerebral malaria.Interferon regulatory factors in human lupus pathogenesisIFN regulatory factors 4 and 8 expression in the NOD mouseAssociation analyses confirm five susceptibility loci for systemic lupus erythematosus in the Han Chinese population.Loss of IRF8 Inhibits the Growth of Diffuse Large B-cell LymphomaComprehensive Transcriptome Meta-analysis to Characterize Host Immune Responses in Helminth Infections.Gene expression comparison of resistant and susceptible Atlantic salmon fry challenged with Infectious Pancreatic Necrosis virus reveals a marked contrast in immune response.The Third Intron of the Interferon Regulatory Factor-8 Is an Initiator of Repressed Chromatin Restricting Its Expression in Non-Immune CellsIFN regulatory factor 8 restricts the size of the marginal zone and follicular B cell pools.The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells.The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases.Notch-RBP-J signaling regulates the transcription factor IRF8 to promote inflammatory macrophage polarization.Interferon regulatory factor 8/interferon consensus sequence binding protein is a critical transcription factor for the physiological phenotype of microglia.Cutting Edge: Expression of IRF8 in Gastric Epithelial Cells Confers Protective Innate Immunity against Helicobacter pylori Infection.Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus.Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypes.Re(de)fining the dendritic cell lineage.The Interferon-Signature of Sjögren's Syndrome: How Unique Biomarkers Can Identify Underlying Inflammatory and Immunopathological Mechanisms of Specific DiseasesGenetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome
P2860
Q24616336-E065AA84-1D69-452B-BAC7-5EF644434801Q26777199-690E939F-3A4C-4FD3-8802-826804078C6FQ27012493-9E2AA168-6456-48F3-9760-E468F7A4341FQ27321749-2D5446AA-D2AF-48A2-8964-BE8DA3179680Q28115493-2D200CBF-84F7-4BB3-8710-D992DF8749FFQ28119162-2D5BC94E-48EF-454A-95AF-53854EE8C531Q28594572-11A6FF24-8E36-43CE-A876-002B7CDAFADAQ30206834-EF7E8647-3EA3-4285-99F8-F67A36DC3870Q33588166-9388705A-4BF5-41DB-B67F-E5ED732337C0Q33764157-162DCEAC-C441-425E-87A6-6647DD240C11Q33951982-A9E20CDB-1EFE-4767-918D-7827702C5609Q34064253-F882505A-453A-4ACD-BDB3-93C2071DBC27Q34105647-CDC6E557-4782-4AE1-BCE2-4BA33DA22D7EQ34125273-D04383ED-BD77-4847-9372-3414FFAE0867Q34230520-8AF749EE-8D42-4BCC-B00A-F4E46468F449Q34375208-5A514B51-F07B-4F3E-B0B1-7AB21A90F627Q34430102-4FCCD033-D5D5-4CD6-856C-D470CA6E51B8Q34458974-50183F36-5988-4E91-8EAE-7F077796FA83Q34482817-BF1CA01F-3FC0-4C0A-B805-0BB915B53578Q34545200-7849BE60-29AD-4B83-84D6-BD0AF871BEE1Q34775356-708D8C64-0267-4C88-A590-16F83D8C3489Q34819713-D121713D-76FD-4DE2-8DD7-5328637AE57EQ34988497-4A35560B-57DC-4889-8AD5-A9E76F257913Q35008547-6E06E4A0-4A76-4FFB-AF67-D9601F65460EQ35496923-2C41AF64-0182-4919-8015-1BAD360EF970Q35978570-F5D0AA38-E448-49B2-B3A8-3CC3B589ECDCQ35983706-A81EE4E5-D494-4361-8535-57A5794E9CA8Q35986203-7C2F7F2A-C064-4F65-A85F-7815F2807197Q36039200-F3F2220D-88C8-4E56-AA67-8FD854DE7FE8Q36121801-D1307603-15EB-4E87-A9A1-989FB1D05811Q36129530-26092417-6285-41D8-B293-473A8656DA45Q36342106-111BA102-5FDC-4FAE-9481-BF2F20001172Q36441894-34E222E6-A540-465A-B93F-6F5A34E95BCBQ36539071-4A743CA7-8E65-4028-B25C-503BFE464280Q36600941-50F23A29-BE16-49B3-8366-7F2F1C7013FBQ36637528-246508B6-9E66-4C10-A57E-CC4043E9732AQ36680976-96B56D91-D460-4474-9CE1-6024F344F01EQ36818027-CBF4B307-7BA7-4882-B918-5F376CC64544Q36983628-FA4B7E81-0EF5-431C-83C3-DCA9CDC7D7B8Q37246532-4523405E-95F5-44D4-B869-781A0CDA923B
P2860
IRF8 regulates myeloid and B lymphoid lineage diversification
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
IRF8 regulates myeloid and B lymphoid lineage diversification
@ast
IRF8 regulates myeloid and B lymphoid lineage diversification
@en
IRF8 regulates myeloid and B lymphoid lineage diversification.
@nl
type
label
IRF8 regulates myeloid and B lymphoid lineage diversification
@ast
IRF8 regulates myeloid and B lymphoid lineage diversification
@en
IRF8 regulates myeloid and B lymphoid lineage diversification.
@nl
prefLabel
IRF8 regulates myeloid and B lymphoid lineage diversification
@ast
IRF8 regulates myeloid and B lymphoid lineage diversification
@en
IRF8 regulates myeloid and B lymphoid lineage diversification.
@nl
P2860
P1433
P1476
IRF8 regulates myeloid and B lymphoid lineage diversification
@en
P2093
Hongsheng Wang
P2860
P2888
P304
P356
10.1007/S12026-008-8055-8
P577
2009-01-01T00:00:00Z
P5875
P6179
1034671752